Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Colorcon
Cipla
Teva
Johnson and Johnson
Fish and Richardson

Generated: August 22, 2019

DrugPatentWatch Database Preview

Details for Patent: RE38912

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Which drugs does patent RE38912 protect, and when does it expire?

Patent RE38912 protects SPIRIVA and is included in one NDA.

Protection for SPIRIVA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has one hundred and sixteen patent family members in forty-nine countries.

Summary for Patent: RE38912
Title: Process for preparing powder formulations
Abstract:The invention relates to a new process for producing powdered preparations for inhalation.
Inventor(s): Walz; Michael (Bingen, DE), Boeck; Georg (Mainz, DE)
Assignee: Boehringer Ingelheim Pharma KG (Ingelheim, DE)
Application Number:10/766,748
Patent Claim Types:
see list of patent claims
Composition; Process; Device; Compound;

Drugs Protected by US Patent RE38912

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Boehringer Ingelheim SPIRIVA tiotropium bromide POWDER;INHALATION 021395-001 Jan 30, 2004 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Subscribe to access the full database, or try a Free Trial

Foreign Priority and PCT Information for Patent: RE38912

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany100 50 635Oct 12, 2000
Germany101 38 022Aug 10, 2001

International Family Members for US Patent RE38912

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 1712 ➤ Sign Up
Argentina 031819 ➤ Sign Up
Argentina 034166 ➤ Sign Up
Austria 275391 ➤ Sign Up
Austria 319422 ➤ Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Medtronic
Johnson and Johnson
Chubb
Colorcon
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.